A decade-long NHS trial has indicated that a targeted prostate cancer treatment, known as focal therapy, significantly reduces the risk of side effects for nearly 3,500 men. This less invasive approach offers a more positive outlook for patients compared to traditional treatments.
The study's findings suggest a major advancement in prostate cancer care within the UK, potentially improving the quality of life for many individuals undergoing treatment.